Erythropoietin or Darbepoetin for patients with cancer-Reference-Cited by-同舟云学术

Erythropoietin or Darbepoetin for patients with cancer

Published:2006-07-19 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Bohlius Julia,Wilson Jayne,Seidenfeld Jerome,Piper Margret,Schwarzer Guido,Sandercock Josie,Trelle Sven,Weingart Olaf,Bayliss Susan,Brunskill Susan,Djulbegovic Benjamin,Bennett Charles,Langensiepen Simon,Hyde Chris,Engert Andreas

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003407.pub4/epdf/full

Reference316 articles.

1. Erythropoietin for anemia in cancer patients;Abels;European Journal of Cancer,1993

2. Recombinant Human Erythropoietin in the Treatment of the Anaemia of Cancer;Abels;Acta Haematologica,1992

3. Johnson and Johnson briefing document for FDA/ODAC hearing May 4, 2004

4. Recombinant human erythropoietin for platinum-based chemotherapy-induced anaemia: A single-centre randomised study;Aravantinos;Journal of B U On,2003

5. Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group;Bamias;Oncology,2003

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA;Supportive Care in Cancer;2022-06-09

2. Prise en charge de l’anémie en situation palliative : synthèse de la littérature;Médecine Palliative;2021-05

3. Prise en charge de l’anémie en situation palliative : synthèse de la littérature;Médecine Palliative;2021-04

4. Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer;Cancers;2021-03-29

5. Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare’s reimbursement policy;Journal of Managed Care & Specialty Pharmacy;2020-11